AnaptysBio, Inc. (ANAB) NASDAQ

54.80

-1.3127(-2.34%)

Updated at February 27 01:37PM

Currency In USD

Valuation

Market Cap375.78M
Enterprise Value622.16M
P/E Ratio-19.15
PEG Ratio-0.52
Price/Sales Ratio9.11
Price/Book Ratio-55.08
Enterprise/Revenue10.5
Enterprise/EBITDA-389.55

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.5
Operating Margin-0.17

Management Effectiveness

Return On Assets-0.24
Return On Equity-11.01

Income Statement

Revenue91.28M
Revenue/Share5.83
Gross Profit-72.56M
EBITDA-92.74M
Net Income-145.23M
Diluted EPS-5.12

Balance Sheet

Total Cash248.96M
Total Cash/Share8.57
Total Debt346.45M
Total Debt/Equity-11.78
Current Ratio8.68
Book Value Per Share-1.01

Price History

52-Week Change239.94
52-Week High57.74
52-Week Low13.99
Moving Average 50 Days49.27
Moving Average 200 Days32.99

Statistics

Average Volume459,219
Shares Outstanding27.69M
% Held by Institutions101

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A